Differences in salivary microbiome among children with tonsillar hypertrophy and/or adenoid hypertrophy

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-1-10
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Xu Y, Yu M, Huang X, Wang G, Wang H, Zhang F, Zhang J, Gao X
Journal
mSystems
Year
2024
Keywords:
16s rRNA sequencing, oral microbiome, tonsillar hypertrophy
Children diagnosed with severe tonsillar hypertrophy display discernible craniofacial features distinct from those with adenoid hypertrophy, prompting illuminating considerations regarding microbiota regulation in this non-inflammatory condition. The present study aimed to characterize the salivary microbial profile in children with tonsillar hypertrophy and explore the potential functionality therein. A total of 112 children, with a mean age of 7.79 ± 2.41 years, were enrolled and divided into the tonsillar hypertrophy (TH) group (n = 46, 8.4 ± 2.5 years old), adenoid hypertrophy (AH) group (n = 21, 7.6 ± 2.8 years old), adenotonsillar hypertrophy (ATH) group (n = 23, 7.2 ± 2.1 years old), and control group (n = 22, 8.6 ± 2.1 years old). Unstimulated saliva samples were collected, and microbial profiles were analyzed by 16S rRNA sequencing of V3-V4 regions. Diversity and composition of salivary microbiome and the correlation with parameters of overnight polysomnography and complete blood count were investigated. As a result, children with tonsillar hypertrophy had significantly higher α-diversity indices (P<0.05). β-diversity based on Bray-Curtis distance revealed that the salivary microbiome of the tonsillar hypertrophy group had a slight separation from the other three groups (P<0.05). The linear discriminant analysis effect size (LEfSe) analysis indicated that Gemella was most closely related to tonsillar hypertrophy, and higher abundance of Gemella, Parvimonas, Dialister, and Lactobacillus may reflect an active state of immune regulation. Meanwhile, children with different degrees of tonsillar hypertrophy shared similar salivary microbiome diversity. This study demonstrated that the salivary microbiome in pediatric tonsillar hypertrophy patients had different signatures, highlighting that the site of upper airway obstruction primarily influences the salivary microbiome rather than hypertrophy severity.IMPORTANCETonsillar hypertrophy is the most frequent cause of upper airway obstruction and one of the primary risk factors for pediatric obstructive sleep apnea (OSA). Studies have discovered that children with isolated tonsillar hypertrophy exhibit different craniofacial morphology features compared with those with isolated adenoid hypertrophy or adenotonsillar hypertrophy. Furthermore, characteristic salivary microbiota from children with OSA compared with healthy children has been identified in our previous research. However, few studies provided insight into the relationship between the different sites of upper airway obstruction resulting from the enlargement of pharyngeal lymphoid tissue at different sites and the alterations in the microbiome. Here, to investigate the differences in the salivary microbiome of children with tonsillar hypertrophy and/or adenoid hypertrophy, we conducted a cross-sectional study and depicted the unique microbiome profile of pediatric tonsillar hypertrophy, which was mainly characterized by a significantly higher abundance of genera belonging to phyla Firmicutes and certain bacteria involving in the immune response in tonsillar hypertrophy, offering novel perspectives for future related research.

Experiment 1


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/08

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Hypertrophy Hypertrophy,hypertrophy
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control + Adenotonsillar hypertrophy (ATH) group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Tonsillar hypertrophy (TH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
These are children diagnosed with severe tonsillar hypertrophy (TH). It was divided into larger tonsillar hypertrophy group THL (n = 26) and smaller tonsillar hypertrophy group THS (n = 20)
Group 0 sample size Number of subjects in the control (unexposed) group
45
Group 1 sample size Number of subjects in the case (exposed) group
46
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0
Matched on Factors on which subjects have been matched on in a case-control study
age


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/08

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Source: FIG 2A-B

Description: Linear discriminant analysis (LDA) scores showing significant taxonomic differences among the Tonsillar hypertrophy (TH) group and ATH + control groups.

Abundance in Group 1: increased abundance in Tonsillar hypertrophy (TH)

NCBI Quality ControlLinks
Actinomyces dentalis
Actinomyces oris
Anaeroglobus geminatus
Bacillaceae
Bacillales
Bacillus
Bacteroides
Bifidobacteriaceae
Bifidobacterium
Candidatus Nanoperiomorbaceae
Candidatus Nanoperiomorbus
Capnocytophaga ochracea
Cardiobacterium valvarum
Dialister
Dialister invisus
Elizabethkingia
Elizabethkingia anophelis
Filifactor
Filifactor villosus
Fusobacterium nucleatum
Gemella
Gemella morbillorum
Gemellaceae
Granulicatella elegans
Haemophilus
Haemophilus sputorum
Lachnospiraceae bacterium UBA3282
Lactobacillaceae
Lactobacillus
Leptotrichia buccalis
Oribacterium sp.
Parvimonas
Parvimonas micra
Pauljensenia hongkongensis
Peptoniphilaceae
Porphyromonas endodontalis
Prevotella intermedia
Prevotella micans
Prevotella nigrescens
Streptococcus constellatus
Tatumella ptyseos
Tissierellales
Treponema denticola
UBA3282 sp003611805UBA3282 sp003611805
DialisteraceaeDialisteraceae
Allisonella pneumosintesAllisonella pneumosintes
StaphylococcalesStaphylococcales

Revision editor(s): Rahila, KateRasheed

Experiment 2


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/08

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control + Tonsillar Hypertrophy (TH) group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Adenotonsillar hypertrophy (ATH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The adenotonsillar hypertrophy (ATH) group consists of children who are diagnosed with Grade III tonsillar hypertrophy and Grade III or IV adenoid hypertrophy simultaneously
Group 0 sample size Number of subjects in the control (unexposed) group
68
Group 1 sample size Number of subjects in the case (exposed) group
23

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/08

Curator: Rahila

Revision editor(s): Rahila, MyleeeA, KateRasheed

Source: FIG 2A-B

Description: Linear discriminant analysis (LDA) scores showing significant taxonomic differences among the adenotonsillar hypertrophy (ATH) group and TH + control groups.

Abundance in Group 1: increased abundance in Adenotonsillar hypertrophy (ATH)

NCBI Quality ControlLinks
Atopobiaceae
Lancefieldella
Megasphaera micronuciformis
Segatella salivae
Veillonella atypica
Lancefieldella sp.

Revision editor(s): Rahila, MyleeeA, KateRasheed

Experiment 3


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/08

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
TH + ATH groups
Group 1 name Corresponds to the case (exposed) group for case-control studies
Control group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Control group refers to children without tonsillar and/or adenoid hypertrophy.
Group 0 sample size Number of subjects in the control (unexposed) group
69
Group 1 sample size Number of subjects in the case (exposed) group
22

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 2A-B

Description: Linear discriminant analysis (LDA) scores showing significant taxonomic differences among the adenotonsillar hypertrophy (ATH) + TH groups and control group.

Abundance in Group 1: increased abundance in Control group

NCBI Quality ControlLinks
Centipeda periodontii
Segatella oulorum
Hoylesella loescheii
Lachnoanaerobaculum saburreum

Revision editor(s): KateRasheed

Experiment 4


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/09

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Tonsillar Hypertrophy (TH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Salivary microbial profile in children with a larger tonsillar hypertrophy group diagnosed with Grade III tonsillar hypertrophy
Group 0 sample size Number of subjects in the control (unexposed) group
22
Group 1 sample size Number of subjects in the case (exposed) group
46

Lab analysis

Statistical Analysis

Statistical test
Kruskall-Wallis
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
Not specified

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 3A

Description: Differential abundance of taxa between control group and tonsillar hypertrophy; using Kruskal-wallis test

Abundance in Group 1: increased abundance in Tonsillar Hypertrophy (TH)

NCBI Quality ControlLinks
Gemella
Dialister
Haemophilus

Revision editor(s): KateRasheed

Experiment 5


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/09

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Adenotonsillar hypertrophy (ATH)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Tonsillar hypertrophy (TH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The salivary microbial profile in children diagnosed with severe tonsillar hypertrophy (TH).
Group 0 sample size Number of subjects in the control (unexposed) group
23

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/09

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Source: Fig. 3A

Description: Differential abundance of taxa between adenoid tonsillar group and tonsillar hypertrophy; using Kruskal-wallis test

Abundance in Group 1: increased abundance in Tonsillar hypertrophy (TH)

NCBI Quality ControlLinks
Bacillus
Bifidobacterium
Filifactor
Gemella
Parvimonas
Treponema

Revision editor(s): Rahila, KateRasheed

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 3B

Description: Differential abundance of taxa between adenoid tonsillar group and tonsillar hypertrophy; using Kruskal-wallis test

Abundance in Group 1: decreased abundance in Tonsillar hypertrophy (TH)

NCBI Quality ControlLinks
Veillonella
Prevotella
Anaeroglobus

Revision editor(s): KateRasheed

Experiment 6


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/09

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Adenoid hypertrophy (AH)
Group 0 sample size Number of subjects in the control (unexposed) group
21

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2024/10/09

Curator: Rahila

Revision editor(s): Rahila, KateRasheed

Source: FIG 3A

Description: Significant taxonomic differences among the tonsillar hypertrophy (TH) group and adenoid hypertrophy (AH) group using Kruskal-Wallis test.

Abundance in Group 1: increased abundance in Tonsillar hypertrophy (TH)

NCBI Quality ControlLinks
Bifidobacterium
Dialister
Gemella
Bacillus

Revision editor(s): Rahila, KateRasheed

Experiment 7


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Control group
Group 1 name Corresponds to the case (exposed) group for case-control studies
Adenoid hypertrophy (AH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The adenoid hypertrophy (AH) group, comprises 21 children diagnosed with Grade III or IV adenoid hypertrophy through fibro-laryngoscopic examination
Group 0 sample size Number of subjects in the control (unexposed) group
22
Group 1 sample size Number of subjects in the case (exposed) group
21

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Richness Number of species
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 3A

Description: Significant taxonomic differences among the control group and adenoid hypertrophy (AH) group using Kruskal-Wallis test.

Abundance in Group 1: increased abundance in Adenoid hypertrophy (AH)

NCBI Quality ControlLinks
Haemophilus

Revision editor(s): KateRasheed

Experiment 8


Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Adenotonsillar hypertrophy (ATH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The adenotonsillar hypertrophy (ATH) group consists of children who are diagnosed with Grade III tonsillar hypertrophy and Grade III or IV adenoid hypertrophy simultaneously
Group 1 sample size Number of subjects in the case (exposed) group
23

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Richness Number of species
unchanged
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-10

Curated date: 2025/01/06

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 3A

Description: Significant taxonomic differences among the ATH and control groups.

Abundance in Group 1: increased abundance in Adenotonsillar hypertrophy (ATH)

NCBI Quality ControlLinks
Haemophilus

Revision editor(s): KateRasheed